Our in vitro metabolic stability showed Gem-Thr is stable in PBS, plasma and a liver microsomal fraction, which demonstrated Gem-Thr is stable in cancer cells overexpressing amino acid transporter. This evidence concerns the gene SLC38A7 and cancer.